See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000810509_2019_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.
| |
xvar |
xval |
| 0 |
LiabilitiesNoncurrent |
64,055 |
| 1 |
LiabilitiesCurrent |
3,378,518 |
| 2 |
remainder_Liabilities |
1,168,494 |
| 3 |
AssetsCurrent |
5,595,756 |
| 4 |
AssetsNoncurrent |
835,107 |
| 5 |
PropertyPlantAndEquipmentNet |
162,172 |
| 6 |
Goodwill |
428,492 |
| 7 |
remainder_Assets |
0 |
| 8 |
GeneralAndAdministrativeExpense |
7,794,771 |
| 9 |
ResearchAndDevelopmentExpense |
4,221,881 |
| 10 |
remainder_Expenses |
-9,753 |
| 11 |
remainder_Revenues |
1,169,351 |
| 12 |
remainder_NetIncome |
-5,276,768 |
| 13 |
remainder_ComprehensiveNetIncome |
1,666 |
| |
yvar |
yval |
| 0 |
Liabilities |
4,611,067 |
| 1 |
Assets |
7,021,527 |
| 2 |
Expenses |
12,006,899 |
| 3 |
Revenues |
1,169,351 |
| 4 |
StockholdersEquity |
2,410,460 |
| 5 |
NetIncome |
-16,114,316 |
| 6 |
ComprehensiveNetIncome |
-16,113,483 |
| 7 |
BaseVar |
15,043,639 |
| 8 |
EconomicCapitalRatio |
-2.42 |
Edgar->Model Mapping
Feature Distribution
Change over Time
